At CD BioGlyco, we leverage over many years of specialized expertise to provide state-of-the-art glycan profiling services, offering unparalleled insights into the intricate world of glycobiology. Our advanced platforms and highly skilled scientific team are dedicated to supporting your research and development initiatives, from fundamental discovery to preclinical research.
Similar in concept to the genome or proteome, glycome is a complete set of glycans and glycoconjugates generated by a cell or organism under specific conditions. Unlike amino acids in proteins or nucleotides in DNA, the monosaccharide units in glycan chains can be interconnected in many distinct ways, so there is no direct template or standard pattern for their biosynthesis. In addition, the structural diversity of oligosaccharide branches, the increased diversity of complex terminal saccharides, and various chemical modifications such as acetylation, phosphorylation, and sulfation, further increase the structural complexity of glycans. These great structural diversities enable glycans to encode a wide range of information, including cellular signaling, molecular recognition, and immune responses.
Identifying and analyzing the structure, quantity, and function of glycans is challenging. However, in recent years, this task has become easier with the advancement of science and technology and the continuous efforts of researchers. A variety of high-resolution and highly sensitive methods are now available, including mass spectrometry-based methods, high-performance liquid chromatography (HPLC), and lectin-based technologies.
At CD BioGlyco, our carefully designed glycan analysis workflow encompasses multiple key stages, from sample preparation to data analysis, to ensure high-quality and reproducible results. Each step is optimized to maximize glycan recovery and analytical precision. Our process is as follows:
We utilize a variety of methods to isolate glycoproteins from serum, cells, tissues, or recombinant proteins. Glycans are then released from their protein backbones using highly specific enzymatic methods (e.g., PNGase F for N-glycans, O-glycosidase for O-glycans) or chemical methods (e.g., reductive β-elimination for O-glycans).
The released glycans are derivatized with fluorescent labels (e.g., 2-AB, 2-AA) or MS tags to enhance detection sensitivity. Following labeling, excess reagents and impurities are removed using methods such as solid-phase extraction (SPE) to ensure that only labeled glycans are analyzed.
Separation is performed using high-performance liquid chromatography (HPLC) or ultra-high-performance liquid chromatography (UHPLC) systems. The choice of column and mobile phase depends on the specific glycan type and complexity to ensure optimal resolution of individual glycan structures.
MS and fragmentation data are collected and processed using bioinformatics software to identify and quantify individual glycan structures.
Journal: Molecules
IF: 4.6
Published: 2021
Results: This study uses capillary electrophoresis (CE) with laser-induced fluorescence detection for N-glycan profiling in type 2 diabetes (T2D) patients' blood. It found N-glycans remained intact after multiple thaw-freeze cycles, with native blood-collection tubes best preserving sialylated structures. Comparisons identified two N-glycans (FA2G1S1 and A2BG2S1) as potential T2D biomarkers, showing 6.4× and 8.2× increases in T2D samples. CE proves efficient for such analysis, offering insights into T2D-related processes, with consistent sample tools vital for comparability.
At CD BioGlyco, our comprehensive glycan profiling services are backed by extensive expertise and advanced technologies designed to accelerate your research discoveries and support your development goals. Please contact us today to discuss how our tailored solutions can help your specific project.
Reference